Inventor
O'HEERON PETE
US18 patents
⚠️ This page may combine multiple inventors who share the name “O'HEERON PETE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SPINALCYTE LLC
10 patentsUS11034934B2Jun 15, 2021
Methods of enhancing fibroblast therapeutic activity
SPINALCYTE LLC7 citations80
US12576112B2Mar 17, 2026
Inhibition of TNF-alpha by fibroblasts and fibroblast exosomes
SPINALCYTE LLC0 citations61
US12544408B2Feb 10, 2026
Prevention and treatment of kidney failure by administration of fibroblasts and products thereof
SPINALCYTE LLC0 citations61
US12508287B2Dec 30, 2025
Treatment of cerebral palsy using fibroblasts
SPINALCYTE LLC0 citations61
US12404494B2Sep 2, 2025
Prevention of recurrent miscarriages through administration of fibroblasts and fibroblast-educated paternal cells
SPINALCYTE LLC0 citations61
US12233094B2Feb 25, 2025
Interaction of fibroblasts and immune cells for activation and uses thereof
SPINALCYTE LLC0 citations61
US12133870B2Nov 5, 2024
Treatment of opioid addiction using fibroblasts and products thereof
SPINALCYTE LLC1 citations61
US12090174B2Sep 17, 2024
Fibroblast therapy for treatment of Duchenne muscular dystrophy
SPINALCYTE LLC1 citations61
US12310991B2May 27, 2025
Stimulation of angiogenesis by fibroblast derived exosomes
SPINALCYTE LLC1 citations60
US10206954B2Feb 19, 2019
Adipose cells for chondrocyte applications
SPINALCYTE LLC1 citations60
FIGENE LLC
5 patentsUS11819555B2Nov 21, 2023
Gene therapy for the regeneration of chondrocytes or cartilage type cells
FIGENE LLC2 citations70
US11975030B2May 7, 2024
Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
FIGENE LLC1 citations60
US11959102B2Apr 16, 2024
Augmentation of fibroblast regenerative activity
FIGENE LLC1 citations60
US11878037B2Jan 23, 2024
Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
FIGENE LLC1 citations60
US11732239B2Aug 22, 2023
Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
FIGENE LLC0 citations60
FIBROBIOLOGICS INC
3 patentsUS12589119B2Mar 31, 2026
Treatment of cachexia using fibroblast cells and products thereof
FIBROBIOLOGICS INC0 citations58
US12544407B2Feb 10, 2026
Fibroblast cell therapy for treatment of osteoporosis
FIBROBIOLOGICS INC0 citations58
US12427169B2Sep 30, 2025
Adipose cells for chondrocyte applications
FIBROBIOLOGICS INC0 citations57